Cargando…

Renal Salt-Wasting Syndrome Induced by Neoadjuvant Chemotherapy Containing Cisplatin – A Case Report

Hyponatremia is one of the most common electrolyte abnormality seen in oncology practice. The underlying pathogenetic mechanism for chemotherapy-induced hyponatremia is renal salt-wasting syndrome (RSWS) and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Fluid restriction is the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jinsi, N, Vimala, A., Nair, Sreeja S, Arya, R, Ravi, Ranjani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916158/ https://www.ncbi.nlm.nih.gov/pubmed/35283575 http://dx.doi.org/10.4103/ijn.IJN_247_19

Ejemplares similares

Cisplatin Decreases ENaC Activity Contributing to Renal Salt Wasting Syndrome
por: Soares, Antonio G., et al.
Publicado: (2020)

Profound hyponatremia and dehydration: A case of cisplatin induced renal salt wasting syndrome
por: George, Tissa Bijoy, et al.
Publicado: (2023)

Cisplatin-Induced Renal Salt Wasting Requiring over 12 Liters of 3% Saline Replacement
por: Pham, Phuong-Chi, et al.
Publicado: (2017)

Two cases of cisplatin-induced permanent renal failure following neoadjuvant chemotherapy for esophageal cancer
por: Sasaki, Tomohiko, et al.
Publicado: (2016)

Superior mesenteric artery syndrome following initiation of cisplatin-containing chemotherapy: a case report
por: Ushiki, Atsuhito, et al.
Publicado: (2012)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins
por: Amini, Arya, et al.
Publicado: (2019)

Syndrome of Inappropriate Antidiuretic Hormone Secretion and Cerebral/Renal Salt Wasting Syndrome: Similarities and Differences
por: Oh, Ji Young, et al.
Publicado: (2015)

Cerebral salt wasting syndrome in craniopharyngioma
por: Santra, Sankari, et al.
Publicado: (2013)

Cerebral salt-wasting syndrome in children: a case report
por: Andrade, OVB, et al.
Publicado: (2007)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
por: Goel, Arun Kumar, et al.
Publicado: (2010)

Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer
por: Fu, Jin Ye, et al.
Publicado: (2022)

Renal Salt Wasting in Patients Treated with High-Dose Cisplatin, Etoposide, and Mitomycin in Patients with Advanced Non-Small Cell Lung Cancer
por: Lee, Yong Koo, et al.
Publicado: (1992)

New Approach to Hyponatremia: High Prevalence of Cerebral/Renal Salt Wasting, Identification of Natriuretic Protein That Causes Salt Wasting
por: Maesaka, John K., et al.
Publicado: (2022)

Effectiveness of neoadjuvant chemotherapy with cisplatin and irinotecan followed by surgery on small-cell carcinoma of the esophagus: A case report
por: Akiyama, Yuji, et al.
Publicado: (2015)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Voluntary Exercise Prevents Cisplatin-Induced Muscle Wasting during Chemotherapy in Mice
por: Hojman, Pernille, et al.
Publicado: (2014)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
por: Hayashi, Tsutomu, et al.
Publicado: (2020)

Determining factors of renal dysfunction during cisplatin chemotherapy
por: Săftescu, Sorin, et al.
Publicado: (2021)

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients
por: Wang, Bing, et al.
Publicado: (2016)

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
por: Melcher, A. A., et al.
Publicado: (1996)

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
por: Matsubara, Nobuaki, et al.
Publicado: (2013)

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
por: Scandurra, Giuseppa, et al.
Publicado: (2015)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Guancial, Elizabeth A., et al.
Publicado: (2016)

A case of pneumatosis intestinalis during neoadjuvant chemotherapy with cisplatin and 5-fluorouracil for esophageal cancer(†)
por: Kouzu, Keita, et al.
Publicado: (2017)

Absence of p53 Overexpression and Favorable Response to Cisplatin‐based Neoadjuvant Chemotherapy in Urothelial Carcinomas
por: Kakehi, Yoshiyuki, et al.
Publicado: (1998)

Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
por: Dai, Huijuan, et al.
Publicado: (2021)

Cerebral salt wasting syndrome due to tuberculous meningitis; a case report
por: Ahmad, Syed, et al.
Publicado: (2016)

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
por: Lee, Franklin C., et al.
Publicado: (2013)

N-terminal B-type natriuretic peptide and renal function parameters in cerebral salt wasting syndrome
por: Spatenkova, V, et al.
Publicado: (2008)

The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
por: Reznik, L. V., et al.
Publicado: (1991)

Cerebral Salt Wasting Syndrome Associated with Status Epilepticus
por: Lee, Jung-Ju
Publicado: (2022)

Demonstration of natriuretic activity in urine of neurosurgical patients with renal salt wasting
por: Youmans, Steven J, et al.
Publicado: (2013)

Neoadjuvant and postoperative chemotherapy with paclitaxel plus cisplatin for the treatment of FIGO stage IB cervical cancer in pregnancy
por: Kong, Tae-Wook, et al.
Publicado: (2014)

Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study
por: Dada, Reyad, et al.
Publicado: (2016)

Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade
por: Goel, Sunny, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study
por: Liu, Tongxin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_el54kmo8ls43vbddnnuano23pv